Form 13-F position report

SAREPTA THERAPEUTICS INC

Reported by TORONTO DOMINION BANK

SRPT 1.25 09/15/27 CUSIP 803607AD2 Manager CIK 0000947263

Reported 0 shares, down 1,075,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 10 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-09-30 1121930
2023-12-31 2548425
2024-03-31 0
2024-06-30 3236900
2024-09-30 0
2024-12-31 2752500
2025-03-31 931700
2025-06-30 729831
2025-09-30 944656
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

10 quarters
Quarterly reported position history for SAREPTA THERAPEUTICS INC held by TORONTO DOMINION BANK.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -1,075,000 (-100.0%) 0 $0 2026-02-17
Q3 2025 Added 1,075,000 +75,000 (7.5%) < 0.01% $944,656 2025-11-14
Q2 2025 Unchanged 1,000,000 0 (0.0%) < 0.01% $729,831 2025-08-14
Q1 2025 Reduced 1,000,000 -1,500,000 (-60.0%) < 0.01% $931,700 2025-05-15
Q4 2024 New 2,500,000 +2,500,000 (0.0%) < 0.01% $2,752,500 2025-02-14
Q3 2024 Reduced 0 -2,506,000 (-100.0%) 0 $0 2024-11-14
Q2 2024 New 2,506,000 +2,506,000 (0.0%) < 0.01% $3,236,900 2024-08-14
Q1 2024 Reduced 0 -2,500,000 (-100.0%) 0 $0 2024-05-14
Q4 2023 Added 2,500,000 +1,500,000 (150.0%) < 0.01% $2,548,425 2024-02-13
Q3 2023 New 1,000,000 +1,000,000 (0.0%) < 0.01% $1,121,930 2023-11-14

Who else reported the position

34 managers reported SAREPTA THERAPEUTICS INC for Q4 2025.

Managers reporting SAREPTA THERAPEUTICS INC in Q4 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
HIGHBRIDGE CAPITAL MANAGEMENT LLC Added 57,306,000 +20,306,000 1.65% $51,747,318 10 qtrs
DG Capital Management LLC Added 22,245,000 +250,000 8.75% $19,954,210 2 qtrs
D E Shaw & Co Inc Reduced 16,897,000 -14,000,000 < 0.01% $15,239,048 3 qtrs
Calamos Advisors LLC Reduced 15,000 -13 0.05% $13,531,050 10 qtrs
LMR Partners LLP Added 14,300,000 +4,300,000 0.02% $12,899,601 2 qtrs
ADVENT CAPITAL MANAGEMENT DE New 10,085,000 +10,085,000 0.18% $9,033,290 1 qtr
BNP Paribas Asset Management Holding S A Reduced 3,500,000 -900,000 < 0.01% $3,147,000 8 qtrs
STATE OF WISCONSIN INVESTMENT BOARD Unchanged 3,000,000 0 < 0.01% $2,668,500 3 qtrs
PALISADE CAPITAL MANAGEMENT LLC NJ Reduced 1,746,000 -1,559,000 0.05% $1,571,400 10 qtrs
FMR LLC Unchanged 0 0 < 0.01% $1,293,333 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
February 17, 2026
Filing type
13F-HR
Position type
Convertible

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.